The receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.
(Nasdaq: HOLX) today announced that its Affirm ® Contrast Biopsy Software, which combines contrast-enhanced diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback